Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Tocris Bioscience™ GSK 2606414
Potent and selective PERK inhibitor; orally bioavailable
$442.50 - $1847.00
Specifications
Purity | >99% |
---|---|
Product Type | GSK 2606414 |
Molecular Weight (g/mol) | 451.44 |
Inhibitors | GSK 2606414 |
Description
Potent and selective protein kinase R-like ER kinase (PERK) inhibitor (IC50 = 0.4 nM). Exhibits >1000-fold selectivity for PERK over HR1 and PKR. Inhibits thapsigargin-induced PERK phosphorylation in lung carcinoma A549 cells. Attenuates subcutaneous pancreatic human tumor xenograft growth in mice. Orally bioavailable.Specifications
>99% | |
GSK 2606414 | |
451.44 | |
GSK 2606414 |
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title